Pulsenmore (PLSM) Equity Ratio (2025)

Pulsenmore's (PLSM) quarterly Equity Ratio came in at 0.82 in Q4 2025.

Pulsenmore (PLSM) Equity Ratio (2025) Analysis & Trends

Pulsenmore has disclosed Equity Ratio across 1 years of filings, most recently posting 0.82 for Q4 2025.

Equity Ratio for Q4 2025 came in at 0.82, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.82 (changed N/A YoY), and the FY2025 annual result was 0.82, changed N/A from the prior year.
Equity Ratio came in at 0.82 for Q4 2025 at Pulsenmore.
In the past five years, Equity Ratio ranged from a high of 0.82 in Q4 2025 to a low of 0.82 in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Ratio (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.47
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.50
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.54
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.59
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.78
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.42
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	0.45
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.29
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.67
10	Pulsenmore	2.29 Mn	-19.38 Mn	-	0.82

Historic Data

Download Data

Date	Value
Dec 31, 2025	0.82